Medical Devices Industry | Healthcare Sector | Mr. David M. Jeffs CEO | OTCQB Exchange | US15115X1072 ISIN |
United States Country | - Employees | - Last Dividend | 5 Nov 2024 Last Split | - IPO Date |
Cell MedX Corp. is a pioneering biotech company engaged in the discovery, development, and commercialization of therapeutic and non-therapeutic products aimed primarily at diseases such as diabetes, Parkinson's disease, high blood pressure, neuropathy, and issues with kidney functions. Initially known as Sports Asylum, Inc., the company underwent a rebranding to Cell MedX Corp. in September 2014. Established in 2010 and based in Carson City, Nevada, Cell MedX Corp. focuses on bringing innovative solutions into the medical field, significantly improving the quality of life for patients suffering from chronic conditions through advanced technology.
Designed for professional use by healthcare practitioners within clinical settings, the eBalance Pro System is an innovative device aimed at enhancing patient wellness and pain management. It operates through the eBalance Console, which serves as the central control unit, executing three pre-programmed microcurrent algorithms: wellness, pain management, and dual, tailored to address the therapeutic needs of patients.
This system is tailored for home use, promoting general wellness and aiding in pain management treatment. Similar to its professional counterpart, the Home System is driven by the eBalance Console, which manages the application of microcurrents in a user-friendly manner, allowing patients to enjoy the benefits of the technology in the comfort of their own homes. It is especially designed for the temporary relief of discomfort in various parts of the body, including the shoulders, waist, back, neck, arms, and legs, making it a versatile tool for managing a range of conditions.